Skip to main content

BASF & Its Former Counsel Reaches $73M Asbestos Settlement

BASF & Its Former Counsel Reaches $73M Asbestos Settlement

Introduction

In a motion, dated 23rd of July, for preliminary approval of the class action settlement, BASF Catalysts LLC and its longtime national counsel agreed to establish a $72.5 million settlement fund to compensate those plaintiffs, who alleged that the company concealed potential asbestos in industrial and commercial talc.

The lawsuits were brought by 20,000 plaintiffs against BASF or its predecessor Engelhard Corp between 1984 and 2011 over its Emtal Talc products, used for manufacturing purposes.

The claims were voluntarily dismissed, settled, or involuntarily dismissed by the trial court before March 2011. The plaintiffs asserted that the dismissals/settlements were done falsely by the company and its former counsel.

The proposed class was revived on appeal by the Third Circuit Court, after which it underwent years of discovery disputes and attempts at mediation.

The proposed class action settlement was the result of more than nine years of contentious litigation and extensive discovery, along with the assistance of mediators. Each plaintiff, who contended about the harm caused by asbestos-containing talc product, will seek between $500 and $175,000 from the fund.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!